ADX/PUREHEALTH (ADX/PUREHEALTH)

Abu Dhabi Securities Exchange: ADX/PUREHEALTH · AED

AED 2.53

-0.02 (-0.8%)· Recorded snapshot

Market cap	28.6B
Revenue (ttm)	28.6B
Net income (ttm)	2.2B
EPS (ttm)	AED 0.19
Shares out	11.1B
P/E (trailing)	13.0x
P/E (forward)	13.5x
Dividend	AED 0.05 (2.14%)
Volume	1,058,843
Beta	0.70

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 28.6B
Net income (ttm): 2.2B
EPS (ttm): AED 0.19
P/E (trailing): 13.0x
P/E (forward): 13.5x
Market cap: 28.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E13.5

P25 n/aP50 n/aP75 n/a

Trailing P/E13

P25 n/aP50 n/aP75 n/a

ROE10.6

P25 n/aP50 n/aP75 n/a

ROIC8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ADX/PUREHEALTH indicators

Market & fundamental data

Available fields

206

Groups with data

Currency

AED

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AED
Country	United Arab Emirates
Country code	AE
Earnings date	2026-10-29
Enterprise value	AED 44.8B
Exchange	Abu Dhabi Securities Exchange
Financial currency	AED
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2021
Industry	General Medical and Surgical Hospitals
Is primary listing	Yes
ISIN number	AEE01362P238
Last earnings date	2026-10-29
Last refreshed	2026-10-29
Market cap	AED 28.6B
Next earnings date	2026-10-29
Price	AED 2.53
Price currency	AED
SIC code	8062
Stock price date	2026-10-29
Symbol	adx/PUREHEALTH
Website	https://purehealth.ae

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	13.32x
Average P/E ratio (3Y)	29.54x
Earnings yield	7.67%
EV/Earnings	20.77x
EV/EBIT	15.06x
EV/EBITDA	9.18x
EV/FCF	16.12x
EV/Sales	1.57x
FCF / EV yield	6.2%
FCF yield	9.72%
Forward P/E	13.53x
Graham number	2.71612
Graham upside	7.36%
Lynch fair value	AED 0.97
Lynch upside	-61.67%
P/B ratio	1.32x
P/E ratio	13.05x
P/FCF ratio	10.29x
P/OCF ratio	7.37x
P/S ratio	1x
PEG ratio	1.03x
Price / tangible book value	4.4x
Price/EBITDA ratio	7.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	10.39%
EBITDA margin	13.76%
Effective tax rate	9.83%
FCF margin	9.71%
Gross margin	24.64%
Operating margin	10.39%
Pretax margin	8.64%
Profit margin	7.54%
ROA	3.46%
ROCE	7.15%
ROE	10.57%
ROIC	8.01%
Tax / revenue	0.85%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	24.18%
EPS growth (Q)	51.68%
EPS growth (QoQ)	104.93%
EPS growth 3Y	-19.96%
FCF growth	-41.62%
FCF growth (Q)	-61.36%
FCF growth 3Y	-11.13%
Gross profit growth	4.39%
Gross profit growth (Q)	24.36%
Gross profit growth 3Y	13.4%
Net income growth	24.18%
Net income growth (Q)	51.68%
Net income growth (QoQ)	104.93%
Net income growth 3Y	-16.63%
OCF growth	-26.87%
OCF growth (Q)	-48.91%
OCF growth 3Y	-2.52%
Operating income growth	22.82%
Operating income growth (Q)	48.92%
Operating income growth 3Y	-8.53%
Revenue growth	6.2%
Revenue growth (Q)	8.51%
Revenue growth (QoQ)	4.49%
Revenue growth 3Y	31.8%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AED -1.1B
Depreciation and amortization	AED 964.3M
EBIT	AED 3B
EBITDA	AED 3.9B
EPS	AED 0.19
FCF per share	AED 0.25
Financing cash flow	AED -1.2B
Free cash flow	AED 2.8B
Gross profit	AED 7B
Income taxes	AED 242.8M
Investing cash flow	AED -5.4B
Net borrowing	AED -801.6M
Net cash flow	AED -2.8B
Net income	AED 2.2B
Operating income	AED 3B
Revenue	AED 28.6B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.39
Book value per share	AED 1.69
Debt / EBITDA	3.7
Debt / equity	0.83
Debt / FCF	6.5
Interest coverage	3.2
Long-term assets	AED 37.2B
Long-term liabilities	AED 19.8B
Net cash (debt)	AED -13.3B
Net cash / market cap	-46.58%
Net debt / EBITDA	3.38
Net debt / equity	0.61
Net debt / FCF	4.79
Piotroski F-Score	4
Property, plant and equipment	AED 19.3B
Shareholders' equity	AED 21.7B
Tangible book value	AED 6.5B
Tangible book value per share	AED 0.58
Total assets	AED 57.2B
Total cash	AED 4.7B
Total debt	AED 18B
Total liabilities	AED 35.5B
WACC	6.78%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.53
Current assets	AED 20B
Current liabilities	AED 15.7B
Current ratio	1.28
Inventory turnover	15.44
Net working capital	AED 1.1B
Quick ratio	1.06
Working capital	AED 4.3B
Working capital turnover	4.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-08-31
Dividend payment years	2
Dividend payout frequency	Annual
Dividend per share	AED 0.05
Dividend yield	2.14%
Ex-dividend date	2026-04-10
FCF payout ratio	21.64%
Last dividend	AED 0.05
Payout ratio	14.27%
Shareholder yield	2.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AED 2.36
1D price change	-0.78%
1M price change	-12.46%
1M total return	-12.46%
1W price change	-2.32%
1W total return	-2.32%
1Y price change	-9.64%
1Y return CAGR	-7.33%
1Y total return	-7.32%
20-day SMA	AED 2.65
200-day SMA	AED 2.41
3M price change	13.96%
3M total return	13.96%
50-day SMA	AED 2.67
50-day SMA vs 200-day SMA	50over200
52-week high	AED 2.93
52-week high date	2026-09-25
52-week low	AED 1.88
52-week low date	2026-03-24
6M price change	17.67%
6M total return	17.67%
All-time high	AED 6.05
All-time high date	2023-12-22
All-time low	AED 1.88
All-time low date	2026-03-24
Average true range (ATR)	AED 0.07
Average volume	1.9M
Beta (1Y)	0.6
Beta (2Y)	0.55
Beta (5Y)	0.7
Change from 52-week high	-13.65%
Change from 52-week low	34.57%
Change from all-time high	-58.18%
Change from all-time low	34.57%
Change from open	-0.78%
Day's gap	0%
Dollar volume	AED 2.7M
High price	AED 2.56
Low price	AED 2.51
Monthly RSI	36.73
Open price	AED 2.55
Position in 52-week range	40%
Previous close	AED 2.55
Price vs 150-day SMA	7.11%
Price vs 20-day SMA	-4.64%
Price vs 200-day SMA	5.07%
Price vs 50-day SMA	-5.1%
Relative volume	0.55
RSI	41.77
Sharpe ratio	-0.23
Sortino ratio	-0.18
Volume	1.1M
Weekly RSI	53.58
YTD price change	-0.78%
YTD total return	1.76%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.5B
Shares change (QoQ)	0%
Shares change (YoY)	-0%
Shares held by insiders	0.23%
Shares held by institutions	0.17%
Shares outstanding	11.1B

Deeper analysis on ADX/PUREHEALTH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ADX/PUREHEALTH report

Is a complete ADX/PUREHEALTH research report available?

No complete published report is available for adx/PUREHEALTH (ADX/PUREHEALTH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ADX/PUREHEALTH (ADX/PUREHEALTH)

Price

Financial snapshot

Fair-value bridge

Latest news · ADX/PUREHEALTH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ADX/PUREHEALTH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ADX/PUREHEALTH

Frequently asked questions